News from the Department of Medicine

  • Cushman & Colleagues' Study Shows Benefits of Early Anticlotting Therapy in Moderate COVID-19
    New trial results from the University of Vermont and an international team of researchers show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could reduce the risk of severe disease and death.
  • UVM Hosts 9th Biennial Stem Cells Conference
    Investigators from across the globe came together virtually July 12-15, 2021 for the University of Vermont-hosted ninth biennial "Stem Cells, Cell Therapies, and Bioengineering in Lung Biology" conference to share the latest research in the field and set priorities for their work in the future.
  • Cushman Discusses VCCBH on Local 22's "What Matters This Week"
    (JUNE 14, 2021) UVM Professor of Medicine Mary Cushman, M.D., M.Sc., co-principal investigator for the Vermont Center on Cardiovascular and Brain Health, was interviewed by anchor Lauren Maloney on Vermont's Local 22 ABC affiliate's "What Matters This Week" program.
  • Diehl & Colleagues' Latest Research Could Benefit Dengue Vaccine Development
    Despite a record number of over 400 million cases in 2019, vaccine development for the mosquito-borne dengue virus has been challenging due to the need to protect equally against all four dengue strains. The discovery of new possible biomarkers to predict clinical and immune responses to dengue virus infection could be critical to informing future vaccines.
  • Class of 2021 Medical Students, Faculty, Staff Recognized at Honors Celebration
    In a salute to graduating medical students’ accomplishments and to honor the faculty and staff who have supported them during their medical education journey, the University of Vermont Larner College of Medicine launched a virtual 2021 Honors Celebration on May 6, 2021.
  • Kirkpatrick Named 2021-22 University Scholar
    The University of Vermont Graduate College has announced that Beth Kirkpatrick, M.D., professor and chair of microbiology and molecular genetics, has been named one or three 2021-2022 University Scholars. The University Scholars program recognizes distinguished UVM faculty members for sustained excellence in research, scholarship, and creative arts.
  • 2020 NNECOS Research Grant Awarded to Dr. Adrianzen & Dr. Zakai
  • Stowe Weekend of Hope
  • Holcombe Named UVM Cancer Center Director & Hematology/Oncology Division Chief
    Randall F. Holcombe, M.D., M.B.A., has been appointed director of the UVM Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. Holcombe will officially begin his tenure August 1, 2021.
  • College Shows Strength in Primary and Rural Care Education in 2022 U.S. News Rankings
    The Larner College of Medicine was ranked 24th for medical education in primary care and 13th for training in rural care in the 2022 U.S. News and World Report Best Graduate Schools rankings, released March 30, 2021.
  • Rubin Honored for 46 Years of Service at College of Medicine
    Faculty, staff, students, alumni, friends, and family gathered virtually March 12 to celebrate Alan Rubin, M.D., associate professor of medicine and psychiatry, whose 46-year-long career at the University of Vermont has touched thousands of lives. Serving as a clinician, teacher, and mentor over the past nearly five decades, Rubin developed an extensive following through the deep connections he forged with his patients, students, and colleagues.
  • UVM Master of Public Health Program Earns National Accreditation
    The University of Vermont Larner College of Medicine is proud to announce that its Master of Public Health Program has earned national accreditation from the Council on Education for Public Health, the independent agency recognized by the U.S. Department of Education to accredit schools of public health and public health programs.
  • A Matter of Trust: Bringing Vaccine Education to New American Communities
    One of the most alarming realizations of the past year has been the clear link between structural racism in the U.S. and the racial and ethnic health disparities that have led to a disproportionate impact of COVID-19 on communities of color. Thanks to the collaboration of numerous partners in Vermont, members of the New American community are getting the education they need to make informed decisions about their health and the COVID-19 vaccine.
  • Carney Featured in WalletHub Article on Healthiest Cities
    (FEBRUARY 8, 2021) Associate Dean for Public Health and Health Policy and Professor of Medicine Jan Carney, M.D, M.P.H., Is featured in a WalletHub article titled "2021's Healthiest & Unhealthiest Cities in America."
  • Virtual Online Foundations Celebration Honors Medical Class of 2023, Faculty, Staff
    Members of the Larner College of Medicine’s medical Class of 2023, leaders, medical educators, and staff gathered virtually January 28 to celebrate the students’ achievements and recognize the faculty and staff who have supported them during an online Foundations Celebration event.
  • Study Warns Mask Mandate Without Education May Raise COVID-19 Spread
    A new study conducted by a team of health economists and public health faculty at the University of Vermont suggests that the behavior public officials are now mandating or recommending to slow the spread of COVID-19--wearing a face covering--should come with a caveat. If not accompanied by proper public education, the practice could lead to more infections.
  • Teaching Academy Honors Inductees, Awardees & Focuses on DEI at Annual Retreat
    Medical education leaders and scholars gathered virtually on January 13 and 14, 2021 for the Larner College of Medicine Teaching Academy’s 2021 Induction and Award Ceremony and Snow Season Education Retreat. Co-presented with the University of Vermont Health Network Medical Group, the ceremony recognized medical educators and kicked off the annual education program, which this year featured several sessions on diversity, equity, and inclusion.
  • UVM Medical Center & Vaccine Testing Center Complete COVID-19 Vaccine Trial Enrollment
    The UVM Medical Center and Vaccine Testing Center have successfully reached and surpassed the targeted number of enrollees for an ongoing Phase 3 clinical trial of the AstraZeneca COVID-19 vaccine.
  • Cancer Rehab Program Transforms to Meet Needs of Survivors During COVID-19
    Despite the many challenges presented by the pandemic, the resilience of UVM Cancer Center patients and continued commitment of providers have led to a silver lining: a way to ensure patients in locations throughout Vermont and upstate New York are receiving the physical and mental health support they need right from the comfort of their own homes.
  • Plante & Colleagues' Study Details First AI Tool to Help Labs Rule-Out COVID-19
    A recent study conducted by collaborators from the University of Vermont and Cedars-Sinai describes the performance of South Burlington, Vt.-based Biocogniv’s new AI-COVID™ software.